Savard P, DesGroseillers L, Rassart E, Poirier Y, Jolicoeur P
J Virol. 1987 Oct;61(10):3266-75. doi: 10.1128/JVI.61.10.3266-3275.1987.
The helper virus has been shown to play a critical role in the development of lymphoma induced by the defective Abelson murine leukemia virus (A-MuLV). Indeed, A-MuLV pseudotyped with some viruses, such as the Moloney MuLV, has been shown to be highly lymphogenic, whereas A-MuLV pseudotyped with other viruses, such as the BALB/c endogenous N-tropic MuLV, has been shown to be devoid of lymphogenic potential (N. Rosenberg and D. Baltimore, J. Exp. Med. 147:1126-1141, 1978; C. D. Scher, J. Exp. Med. 147: 1044-1053, 1978). To map the viral DNA sequences encoding the determinant of the lymphogenic potential of Moloney MuLV when complexed with A-MuLV, we constructed chimeric helper viral DNA genomes in vitro between parental cloned infectious viral DNA genomes from Moloney MuLV and from BALB/c endogenous N-tropic MuLV. Chimeric helper MuLVs, recovered after transfection of NIH 3T3 cells were used to rescue A-MuLV, and the pseudotypes were inoculated into newborn NIH Swiss, CD-1, and SWR/J mice to test their lymphogenic potential. We found that a 0.44-kilobase-pair PstI-KpnI long terminal repeat-containing fragment from the Moloney MuLV was sufficient to confer some, but not complete, lymphogenic potential to a chimeric virus (p7M2) in NIH Swiss and SWR/J mice, but not in CD-1 mice. The addition of the 3'-end env sequences (comprising the carboxy terminus of gp70 and all p15E) to the U3 long terminal repeat sequences restored the full lymphogenic potential of the Moloney MuLV. Our data indicate that the 3'-end sequences of the helper Moloney MuLV are somehow involved in the development of lymphoma induced by A-MuLV. The same sequences have previously been found to harbor the determinant of leukemogenicity and of disease specificity of Moloney MuLV when inoculated alone.
辅助病毒已被证明在由缺陷型阿贝尔森鼠白血病病毒(A-MuLV)诱导的淋巴瘤发展中起关键作用。实际上,用某些病毒(如莫洛尼鼠白血病病毒)假型化的A-MuLV已被证明具有高度致淋巴瘤性,而用其他病毒(如BALB/c内源性N-嗜性鼠白血病病毒)假型化的A-MuLV已被证明没有致淋巴瘤潜力(N. 罗森伯格和D. 巴尔的摩,《实验医学杂志》147:1126 - 1141,1978;C. D. 舍尔,《实验医学杂志》147:1044 - 1053,1978)。为了定位与A-MuLV复合时编码莫洛尼鼠白血病病毒致淋巴瘤潜力决定因素的病毒DNA序列,我们在体外构建了来自莫洛尼鼠白血病病毒和BALB/c内源性N-嗜性鼠白血病病毒的亲本克隆感染性病毒DNA基因组之间的嵌合辅助病毒DNA基因组。转染NIH 3T3细胞后回收的嵌合辅助鼠白血病病毒用于拯救A-MuLV,并将假型接种到新生的NIH瑞士小鼠、CD-1小鼠和SWR/J小鼠中以测试它们的致淋巴瘤潜力。我们发现,来自莫洛尼鼠白血病病毒的一个含0.44千碱基对PstI - KpnI长末端重复序列的片段足以赋予嵌合病毒(p7M2)在NIH瑞士小鼠和SWR/J小鼠中一定但不完全的致淋巴瘤潜力,但在CD-1小鼠中则不然。将3'端env序列(包括gp70的羧基末端和所有p15E)添加到U3长末端重复序列中可恢复莫洛尼鼠白血病病毒的完全致淋巴瘤潜力。我们的数据表明,辅助莫洛尼鼠白血病病毒的3'端序列以某种方式参与了A-MuLV诱导的淋巴瘤的发展。之前发现相同的序列在单独接种时包含莫洛尼鼠白血病病毒的致白血病性和疾病特异性决定因素。